The device is meant to treat atrial fibrillation patients who are unable to tolerate blood thinners to reduce stroke risk. It works by sealing the left atrial appendage — a small pouch connected to the heart’s upper left chamber — to prevent clots from forming in the area, the system said in a March 28 news release sent to Becker’s.
“The treatment option opens the door for many more patients who cannot be on blood thinners for even a short period. It also allows the LAA closure for different shapes and sizes,” said Ruby Satpathy, MD, an interventional cardiologist who implanted the device in a 75-year-old patient.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
